Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 1761-1767, 1995;
This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nauck, M.
Right arrow Articles by Wieland, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nauck, M.
Right arrow Articles by Wieland, H.

Clinical Chemistry, Vol 41, 1761-1767, Copyright © 1995 by American Association for Clinical Chemistry

Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining

M Nauck, K Winkler, W Marz and H Wieland
Department of Medicine, University Hospital of Freiburg, Germany.

Quantification of lipoprotein cholesterol was performed by enzymatic staining of cholesterol in a new agarose gel electrophoresis method that allows the separation of LDL, VLDL, HDL, and lipoprotein(a) [Lp(a)]. Lp(a) shows an electrophoretic mobility clearly distinct from VLDL and HDL. The total CVs of lipoprotein cholesterol varied between 2.7% and 3.9% for LDL, 7.8% and 23.2% for VLDL, 5.2% and 9.5% for HDL, and 6.8% and 16.4% for Lp(a). Comparison of LDL-, VLDL-, and HDL- cholesterol concentrations with the results of a combined ultracentrifugation and precipitation technique gave correlation coefficients of 0.961, 0.947, and 0.918, respectively; comparison of Lp(a)-cholesterol values with those of a nephelometric Lp(a) assay gave r = 0.906. The new electrophoretic assay has several advantages: It allows the quantification of Lp(a)-cholesterol; VLDL-cholesterol is not affected by Lp(a)-cholesterol; and the LDL-cholesterol fraction does not contain Lp(a)-cholesterol, as happens with LDL-cholesterol determined by ultracentrifugation and precipitation.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Virol.Home page
H. Barth, E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, et al.
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells
J. Virol., April 1, 2008; 82(7): 3466 - 3479.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. B. Schwedler, K. Amann, K. Wernicke, A. Krebs, M. Nauck, C. Wanner, L. A. Potempa, and J. Galle
Native C-Reactive Protein Increases Whereas Modified C-Reactive Protein Reduces Atherosclerosis in Apolipoprotein E-Knockout Mice
Circulation, August 16, 2005; 112(7): 1016 - 1023.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Wanner, V. Krane, W. Marz, M. Olschewski, J. F.E. Mann, G. Ruf, E. Ritz, and the German Diabetes and Dialysis Study Investigato
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
N. Engl. J. Med., July 21, 2005; 353(3): 238 - 248.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
H. Hidaka, M. Tozuka, B. Meyer, K. Yamauchi, M. Sugano, T. Nakabayashi, and T. Katsuyama
Characterization of Triglyceride Rich Lipoproteins with Very Light Density by Ultracentrifugation and Agarose Gel Electrophoresis using Triglyceride- and Cholesterol-Staining
Ann. Clin. Lab. Sci., April 1, 2003; 33(2): 167 - 178.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Meinertz, K. Nilausen, and J. Hilden
Alcohol-Extracted, but Not Intact, Dietary Soy Protein Lowers Lipoprotein(a) Markedly
Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 312 - 316.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Nauck, G. R. Warnick, and N. Rifai
Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation
Clin. Chem., February 1, 2002; 48(2): 236 - 254.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Paultre, C. H. Tuck, B. Boden-Albala, D. E. Kargman, E. Todd, J. Jones, M. C. Paik, R. L. Sacco, and L. Berglund
Relation of Apo(a) Size to Carotid Atherosclerosis in an Elderly Multiethnic Population
Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 141 - 146.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. R. Warnick, M. Nauck, and N. Rifai
Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays
Clin. Chem., September 1, 2001; 47(9): 1579 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Paultre, T. A. Pearson, H. F. C. Weil, C. H. Tuck, M. Myerson, J. Rubin, C. K. Francis, H. F. Marx, E. F. Philbin, R. G. Reed, et al.
High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men
Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2619 - 2624.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Benlian, C. Cansier, G. Hennache, O. Khallouf, P. Bayer, F. Duron, F. Carrat, R. Couderc, O. Chazouilleres, J. Bardet, et al.
Comparison of a New Method for the Direct and Simultaneous Assessment of LDL- and HDL-Cholesterol with Ultracentrifugation and Established Methods
Clin. Chem., April 1, 2000; 46(4): 493 - 505.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Nauck, W. Marz, and H. Wieland
Is Lipoprotein(a) Cholesterol a Significant Indicator of Cardiovascular Risk?
Clin. Chem., March 1, 2000; 46(3): 436 - 437.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Schlenck, B. Herbeth, G. Siest, and S. Visvikis
Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
J. Lipid Res., November 1, 1999; 40(11): 2125 - 2133.
[Abstract] [Full Text]


Home page
JAMAHome page
J. T. Moroney, M.-X. Tang, L. Berglund, S. Small, C. Merchant, K. Bell, Y. Stern, and R. Mayeux
Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke
JAMA, July 21, 1999; 282(3): 254 - 260.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Sugiuchi, T. Irie, Y. Uji, T. Ueno, T. Chaen, K. Uekama, and H. Okabe
Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and {alpha}-cyclodextrin sulfate
Clin. Chem., March 1, 1998; 44(3): 522 - 531.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. H. Tuck, S. Holleran, and L. Berglund
Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women
Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1822 - 1829.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.